diff options
Diffstat (limited to 'derivation_to_json/example.2.raw')
| -rw-r--r-- | derivation_to_json/example.2.raw | 20 |
1 files changed, 13 insertions, 7 deletions
diff --git a/derivation_to_json/example.2.raw b/derivation_to_json/example.2.raw index 7fed320..453d2ce 100644 --- a/derivation_to_json/example.2.raw +++ b/derivation_to_json/example.2.raw @@ -1,10 +1,16 @@ -({<0,21> [Goal] ||| [S] ||| [1]}({<0,21> [S] ||| [S] [X] ||| [1] [2]}({<0,13> [S] ||| [X] ||| [1]}({<0,13> [X] ||| [X] metalloxid @-@ halbleitern , ||| [1] @-@ oxide semiconductors and which}({<0,9> [X] ||| die [X] auf basis von ||| the [1] which are based on metal}({<1,6> [X] ||| [X] bezieht sich auf gassensoren ||| [1] relates to gas sensors}({<1,2> [X] ||| neuerung ||| invention}) ) ) ) ) ({<13,21> [X] ||| die sehr [X] sind . ||| are very [1] .}({<15,19> [X] ||| empfindlich und wenig temperaturabhängig ||| sensitive and not appreciably temperature @-@ dependent}) ) ) ) -[X] ||| neuerung ||| invention ||| ForceRule=1 ||| 0-0 -[X] ||| [X] bezieht sich auf gassensoren ||| [1] relates to gas sensors ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.45124 MaxLexFgivenE=2.73473 CountEF=0.477121 SampleCountF=0.477121 EgivenFCoherent=-0 ||| 1-1 1-2 2-1 4-3 4-4 -[X] ||| die [X] auf basis von ||| the [1] which are based on metal ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=5.95916 MaxLexFgivenE=3.2265 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 0-0 2-4 3-4 3-5 4-6 -[X] ||| [X] metalloxid @-@ halbleitern , ||| [1] @-@ oxide semiconductors and which ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=3.79715 MaxLexFgivenE=2.26688 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 1-2 2-1 3-3 4-5 +({<0,29> [Goal] ||| [S] ||| [1]}({<0,29> [S] ||| [S] [X] ||| [1] [2]}({<0,14> [S] ||| [X] ||| [1]}({<0,14> [X] ||| [X] zur Erfindung [X] ||| the invention [1] relates to [2]}({<0,2> [X] ||| weiterhin gehört ||| also}) ({<4,14> [X] ||| [X] Herz-Kreislauf-Erkrankungen ||| [1] cardiovascular diseases}({<4,13> [X] ||| [X] Therapie und Prophylaxe von ||| [1] therapy and prophylaxis of}({<4,9> [X] ||| die Verwendung dieser Zusammensetzungen zur ||| the use of said compositions for the}) ) ) ) ) ({<14,29> [X] ||| , Erkrankungen [X] Krebserkrankungen [X] ||| , diseases [1] cancerous diseases [2]}({<16,27> [X] ||| im Zusammenhang [X] oder ||| in conjunction [1] or}({<18,26> [X] ||| [X] , Knochenerkrankungen ||| [1] , osteopathy}({<18,24> [X] ||| mit einer erhöhten [X] ||| with an increased [1]}({<21,24> [X] ||| Thrombozytenaggregation , [X] ||| the platelet aggregation , [1]}({<23,24> [X] ||| Stoffwechsel-Erkrankungen ||| metabolism illnesses}) ) ) ) ) ({<28,29> [X] ||| . ||| .}) ) ) ) +[X] ||| weiterhin gehört ||| also ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=0.458975 MaxLexFgivenE=4.79441 CountEF=0.30103 SampleCountF=0.477121 EgivenFCoherent=0.30103 ||| 0-0 1-0 +[X] ||| die Verwendung dieser Zusammensetzungen zur ||| the use of said compositions for the ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=2.93053 MaxLexFgivenE=3.26928 CountEF=0.30103 SampleCountF=0.69897 EgivenFCoherent=0.60206 ||| 0-0 1-1 2-3 3-4 4-5 +[X] ||| [X] Therapie und Prophylaxe von ||| [1] therapy and prophylaxis of ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.926982 MaxLexFgivenE=1.42237 CountEF=0.90309 SampleCountF=1.47712 EgivenFCoherent=0.6173 ||| 1-1 2-2 3-3 4-4 +[X] ||| [X] Herz-Kreislauf-Erkrankungen ||| [1] cardiovascular diseases ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.739399 MaxLexFgivenE=0.797149 CountEF=1.38021 SampleCountF=1.69897 EgivenFCoherent=0.328468 ||| 1-1 1-2 +[X] ||| [X] zur Erfindung [X] ||| the invention [1] relates to [2] ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=0 MaxLexEgivenF=3.63316 MaxLexFgivenE=1.80404 CountEF=0.30103 SampleCountF=1.27875 EgivenFCoherent=1.25527 ||| 1-4 2-3 [S] ||| [X] ||| [1] -[X] ||| empfindlich und wenig temperaturabhängig ||| sensitive and not appreciably temperature @-@ dependent ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=6.5059 MaxLexFgivenE=1.51642 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 0-0 1-1 2-3 3-3 3-4 3-6 -[X] ||| die sehr [X] sind . ||| are very [1] . ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=0.456219 MaxLexFgivenE=2.16613 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 0-0 1-1 3-3 4-3 +[X] ||| Stoffwechsel-Erkrankungen ||| metabolism illnesses ||| ForceRule=1 ||| 0-0 0-1 +[X] ||| Thrombozytenaggregation , [X] ||| the platelet aggregation , [1] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=2.11327 MaxLexFgivenE=1.16228 CountEF=0.477121 SampleCountF=0.69897 EgivenFCoherent=0.30103 ||| 0-1 0-2 +[X] ||| mit einer erhöhten [X] ||| with an increased [1] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.72017 MaxLexFgivenE=2.04771 CountEF=0.954243 SampleCountF=1.6902 EgivenFCoherent=0.778151 ||| 0-0 1-1 2-2 +[X] ||| [X] , Knochenerkrankungen ||| [1] , osteopathy ||| IsSupportedOnline=0 IsSingletonFE=1 IsSingletonF=1 MaxLexEgivenF=1.11792 MaxLexFgivenE=0.186321 CountEF=0.30103 SampleCountF=0.30103 EgivenFCoherent=-0 ||| 1-1 2-2 +[X] ||| im Zusammenhang [X] oder ||| in conjunction [1] or ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.43987 MaxLexFgivenE=2.45332 CountEF=0.778151 SampleCountF=1.44716 EgivenFCoherent=0.732394 ||| 0-0 1-1 3-3 +[X] ||| . ||| . ||| IsSupportedOnline=1 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=0.0201086 MaxLexFgivenE=0.135104 CountEF=2.39967 SampleCountF=2.48287 EgivenFCoherent=0.0835026 ||| 0-0 +[X] ||| , Erkrankungen [X] Krebserkrankungen [X] ||| , diseases [1] cancerous diseases [2] ||| IsSupportedOnline=0 IsSingletonFE=0 IsSingletonF=0 MaxLexEgivenF=1.3856 MaxLexFgivenE=0.862494 CountEF=0.477121 SampleCountF=0.778151 EgivenFCoherent=0.39794 ||| 0-0 1-1 3-3 3-4 [S] ||| [S] [X] ||| [1] [2] ||| Glue=1 [Goal] ||| [S] ||| [1] |